Drug Information

Drug General Information
Drug ID
D0L1UH
Former ID
DIB008533
Drug Name
ASP-0777
Indication Alzheimer disease [ICD9: 331; ICD10:G30] Phase 1 [523568]
Company
Astellas Pharma Inc
Target and Pathway
Target(s) NMDA receptor Target Info Modulator [551922]
References
Ref 523568ClinicalTrials.gov (NCT01406145) A Study of the Safety and Tolerability of ASP0777 in Subjects With Alzheimer's Disease (AD) Taking a Stable Dose of Donepezil. U.S. National Institutes of Health.
Ref 551922US patent application no. 2011,0262,442, Compositions for treating cns disorders.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.